Table 3.
Comparative antimicrobial efficacy of biosynthesized B. tomentosa Linn flower-powder extract-derived$ AgNPs.
| Antioxidant Efficacy, AgNPs $; IC50 (AgNPs & Ascorbic Acid (Control), Respectively) [μg/mL] |
Antioxidant Efficacy, Other AgNPs; IC50 (AgNPs & Ascorbic Acid (Control), Respectively) [μg/mL] |
Antimicrobial (Antibacterial) Efficacy, AgNPs $; Zone Inhibition [mm] |
Antimicrobial (Antibacterial) Efficacy, Other AgNPs; Zone Inhibition [mm] |
Antimicrobial (Antifungal) Efficacy, AgNPs $; Zone Inhibition [mm] |
Antimicrobial (Antifungal) Efficacy, Other AgNPs; Zone Inhibition [mm] |
References | |
|---|---|---|---|---|---|---|---|
| 1 | 56.77 & 43.03 | 50.37 & 44.10 | [47,63] | ||||
| 2 | 46.25 & 41.86 | [95] | |||||
| 3 | 6.75 (E. coli) (30 μL) |
11.4 (E. coli) (50 μL) |
[57,67] | ||||
| 4 | 9.25 (S. aureus) (30 μL) |
12.7 (S. aureus) (50 μL) |
[56,67] | ||||
| 5 | 5.75 (C. albicans) (30 μL) |
10.7 (C. albicans) (50 μL) |
[39,97,98] | ||||
| 6 | 7 (A. Flavus) (30 μL) |
20 (A. Flavus) (50 μL) |
[97,98] |